BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2943998)

  • 1. Discriminative and aversive stimulus effects of beta-carboline ethyl ester in rhesus monkeys.
    Takada K; Winger GD; Cook J; Larscheid P; Woods JH
    NIDA Res Monogr; 1986; 67():119-24. PubMed ID: 2943998
    [No Abstract]   [Full Text] [Related]  

  • 2. Discriminative and aversive properties of beta-carboline-3-carboxylic acid ethyl ester, a benzodiazepine receptor inverse agonist, in rhesus monkeys.
    Takada K; Winger G; Cook J; Larscheid P; Woods JH
    Life Sci; 1986 Mar; 38(11):1049-56. PubMed ID: 3005790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of the discriminative stimulus effects of positive gamma-aminobutyric acid(A) modulators in rhesus monkeys discriminating midazolam.
    Lelas S; Gerak LR; France CP
    J Pharmacol Exp Ther; 2000 Sep; 294(3):902-8. PubMed ID: 10945839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative GABA(A) modulators attenuate the discriminative stimulus effects of benzodiazepines and the neuroactive steroid pregnanolone in rhesus monkeys.
    McMahon LR; France CP
    Psychopharmacology (Berl); 2005 Oct; 181(4):697-705. PubMed ID: 15983789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus effects of benzodiazepine agonists and partial agonists in pentobarbital-trained rhesus monkeys.
    Rowlett JK; Woolverton WL
    Behav Pharmacol; 1998 Mar; 9(2):81-92. PubMed ID: 10065928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselective discriminative stimulus effects of zopiclone in rhesus monkeys.
    McMahon LR; Jerussi TP; France CP
    Psychopharmacology (Berl); 2003 Jan; 165(3):222-8. PubMed ID: 12434260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminative stimulus effects of flumazenil in untreated and in diazepam-treated rhesus monkeys.
    Gerak LR; France CP
    Psychopharmacology (Berl); 1999 Oct; 146(3):252-61. PubMed ID: 10541724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apparent pA2 values of benzodiazepine antagonists and partial agonists in monkeys.
    Paronis CA; Bergman J
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1222-9. PubMed ID: 10454498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bidirectional effects of benzodiazepine binding site ligands in the passive avoidance task: differential antagonism by flumazenil and beta-CCt.
    Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
    Behav Brain Res; 2005 Mar; 158(2):293-300. PubMed ID: 15698896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus effects of flumazenil in rhesus monkeys treated chronically with chlordiazepoxide.
    France CP; Gerak LR
    Pharmacol Biochem Behav; 1997 Mar; 56(3):447-55. PubMed ID: 9077582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative stimulus effects of positive GABAA modulators and other anxiolytics, sedatives, and anticonvulsants in untreated and diazepam-treated monkeys.
    McMahon LR; France CP
    J Pharmacol Exp Ther; 2003 Jan; 304(1):109-20. PubMed ID: 12490581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus effects of zolpidem in squirrel monkeys: role of GABA(A)/alpha1 receptors.
    Rowlett JK; Spealman RD; Lelas S; Cook JM; Yin W
    Psychopharmacology (Berl); 2003 Jan; 165(3):209-15. PubMed ID: 12420154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential behavioral effects of low efficacy positive GABAA modulators in combination with benzodiazepines and a neuroactive steroid in rhesus monkeys.
    McMahon LR; France CP
    Br J Pharmacol; 2006 Feb; 147(3):260-8. PubMed ID: 16331290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of behavioral effects of bretazenil by flumazenil and ZK 93,426 in pigeons.
    Witkin JM; Acri JB; Gleeson S; Barrett JE
    Pharmacol Biochem Behav; 1997 Jan; 56(1):1-7. PubMed ID: 8981602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potency of positive gamma-aminobutyric acid(A) modulators to substitute for a midazolam discriminative stimulus in untreated monkeys does not predict potency to attenuate a flumazenil discriminative stimulus in diazepam-treated monkeys.
    McMahon LR; Gerak LR; France CP
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1227-35. PubMed ID: 11504825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The discriminative stimulus properties of cocaine and d-amphetamine: a comparison of three routes of administration.
    de la Garza R; Johanson CE; Schuster CR
    NIDA Res Monogr; 1984 Mar; 49():150-5. PubMed ID: 6434953
    [No Abstract]   [Full Text] [Related]  

  • 17. Naltrexone discrimination in morphine-treated monkeys.
    France CP; Woods JH
    NIDA Res Monogr; 1989; 95():298-9. PubMed ID: 2640973
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on benzodiazepines and opioids administered alone and in combination in rhesus monkeys: ventilation and drug discrimination.
    Gerak LR; Brandt MR; France CP
    Psychopharmacology (Berl); 1998 May; 137(2):164-74. PubMed ID: 9630003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of GABAA receptor subtypes to the anxiolytic-like, motor, and discriminative stimulus effects of benzodiazepines: studies with the functionally selective ligand SL651498 [6-fluoro-9-methyl-2-phenyl-4-(pyrrolidin-1-yl-carbonyl)-2,9-dihydro-1H-pyridol[3,4-b]indol-1-one].
    Licata SC; Platt DM; Cook JM; Sarma PV; Griebel G; Rowlett JK
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1118-25. PubMed ID: 15687371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug discrimination analysis of midazolam under a three-lever procedure. II: Differential effects of benzodiazepine receptor agonists.
    Sannerud CA; Ator NA
    J Pharmacol Exp Ther; 1995 Oct; 275(1):183-93. PubMed ID: 7562548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.